Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06506942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The TRICURE EFS Study

Study acronym: TRICURE EFS
StatusRecruiting
PhaseNot applicable
SponsorTRiCares
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 9 to 10v12
  2. Study sites: 8 to 9v11
  3. Primary completion date: Mar 2026 to Mar 2027
    • Site details revised at 7 of 8 sites
    v10
  4. Enrollment target: 10 to 15
    • Primary completion date: Oct 2025 to Mar 2026
    • Study completion date: Oct 2030 to Mar 2031
    v9
  5. Lead sponsor: [Redacted] to TRiCaresv8 Show 6 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary completion date: Oct 2025
    • Study completion date: Oct 2030
    • Start date: Sep 11, 2024
    • Study sites: 4 to 8
    • Study title shortened, about 9 words
Show 6 earlier versionsHide 6 earlier versions
  1. Lead sponsor: TRiCares to [Redacted]v7 Show 5 more changesShow less
    • Trial status: Recruiting to Withheld
    • Primary completion date: Oct 2025 to not stated
    • Study completion date: Oct 2030 to not stated
    • Start date: Sep 11, 2024 to not stated
    • Study title expanded, about 9 words
  2. Site details revised at 4 of 4 sitesv6
  3. Study sites: 3 to 4
    • Study title shortened, about 1 word
    v5
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 2 to 3
    • Start date changed from estimate of Oct 2024 to Sep 11, 2024
    v4
  5. Re-verified, no change to tracked fieldsv3
  6. Lead sponsor: [Redacted] to TRiCaresv2 Show 5 more changesShow less
    • Trial status: Withheld to Not Yet Recruiting
    • Primary completion date: Oct 2025
    • Study completion date: Oct 2030
    • Start date: Oct 2024
    • Study title shortened, about 8 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
TRiCares
4 trials monitored
See all monitored trials
Heart Disease
8,786 trials monitored
See 412 trials at risk
Prospective, multi-center study to assess safety and performance of the TRiCares Topaz Tricuspid Valve Replacement System
Trial Details
NCT Number NCT06506942
Lead Sponsor TRiCares
Conditions
(from sponsor)		 Tricuspid Valve Regurgitation, Heart Valve Diseases, Cardiovascular Diseases
Related terms Cardiovascular Diseases, Heart Valve Diseases, Tricuspid Valve Insufficiency
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov